Formation Bio Raises $600M Fund to Accelerate AI-Driven Drug Development

AI drugmaker Formation Bio has launched a $600 million Drug Development Accelerator Fund backed by investors including a16z, aiming to use AI to speed up clinical drug development as part of its goal of building an enduring AI-native pharma company.

2026-10-28 ~ 2026-10-29 · 2 related posts

• Formation Bio raises $600M fund to scale AI-powered drug development — a16z · 2026-10-28
• Formation Bio launches $600M AI-native drug development accelerator fund — anshulkundaje · 2026-10-29